-
You're being watched: Japan battles online abuse of athletes
-
US court expedites Anthropic's legal battle with Department of War
-
Badminton to trial synthetic shuttlecocks because of feather shortage
-
Firm, fast Augusta set to test golf's best in 90th Masters
-
BTS to kick off world tour after landmark Seoul comeback
-
Grand National had to change to survive, says former winning jockey
-
Maple syrup or nutella? PM Carney calls Canadian Artemis astronaut
-
Comedy duo Flight of the Conchords reunion gigs sell out in minutes
-
US-Iran truce enters second day as war flares in Lebanon
-
Trump blasts NATO after closed-door Rutte meeting
-
Houston, we have a problem ... with the toilet
-
Slot admits Liverpool in 'survival mode' in PSG defeat
-
Trump makes up with Sahel juntas, with eye on US interests
-
Tiger Woods drug records to be subpoenaed by prosecutors
-
England's Rai wins Par-3 Contest to risk Masters curse
-
Brazil's Chief Raoni backs Lula in elections
-
Trump to discuss leaving NATO in meeting with Rutte
-
Atletico punish 10-man Barcelona, take control of Champions League tie
-
Dominant PSG leave Liverpool right up against it in Champions League tie
-
Meta releases first new AI model since shaking up team
-
Tehran residents relieved but divided by Trump truce
-
Vance says up to Iran if it wants truce to 'fall apart' over Lebanon
-
US, Iran truce hangs in balance as war flares in Lebanon
-
Scale of killing in Lebanon 'horrific': UN rights chief
-
'Ketamine Queen' jailed for 15 years over Matthew Perry drugs
-
Betis earn draw in Europa League quarter-final at Braga
-
Buttler hits form with IPL fifty as Gujarat win last-ball thriller
-
'Total victory' or TACO? Trump faces questions on Iran deal
-
Medvedev thrashed at Monte Carlo as Zverev battles through
-
Trump to discuss leaving NATO in meeting with Rutte: White House
-
Five US multiple major champions seek first Masters win
-
Howell got McIlroy ball as kid and now joins him at Masters
-
Turkey puts 11 on trial for LGBT 'obscenity'
-
Augusta boss eyes tradition and innovation balance at Masters
-
In Trump war on Iran, tactical wins and long-term damage to US
-
Argentine MPs to debate watered-down glaciers protection
-
Brazilian police dog sniffs out 48 tons of marijuana in record bust
-
Leicester close to third tier after points deduction appeal dismissed
-
In the heart of Beirut, buildings in flames and charred cars
-
Dilemma over crossings as fate of Hormuz ships remains uncertain
-
Laurance 'becomes someone else' to nab Tour of the Basque Country stage win
-
Mediators to 'fragile' US-Iran truce urge restraint as violations reported
-
Laurance pips Arrieta to Tour of the Basque Country third stage win
-
US, Iran ceasefire sees Israel's war goals left hanging
-
'Unfinished business': Opponents anxious, bitter after Iran ceasefire
-
Dutch minister says not planning to bar Kanye West
-
France unveils rearmament boost to face Russia threat
-
Suspect remains silent in Swiss bar fire probe
-
Italy great Parisse appointed Azzurri forwards coach
-
Iran truce spurs hopes for world economy, but recovery will be rocky
AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast
Bionoid Pharma (OTC PINK:BINP) unveils AI Maverick's game-changing sales automation in the latest episode of the BizUnLearned Podcast. Discover how this revolutionary platform is set to transform the traditional sales process, one touchpoint at a time.
"Imagine a world where technology doesn't just assist your sales teams but replaces repetitive tasks entirely," highlighted in the podcast. "AI Maverick learns, adapts, and delivers results, letting your team focus on strategy.
Revolutionizing Sales with AI-Powered Automation
Built to solve the most common challenges of traditional sales teams, such as high SDR turnover, inefficiency, and inconsistent messaging, AI Maverick uses advanced AI and automation to replace fragmented sales processes with a unified, intelligent system.
Unmatched Sales Velocity and Scale: AI Maverick addresses inefficiencies in lead targeting and follow-ups with two-way communication, acting swiftly on buyer intent signals. Whether handling 10, 100 or 100,000 interactions, the platform scales effortlessly, ensuring 24/7 engagement without compromising efficiency or personalization.
Seamless Integration: The technology streamlines data management and reduces the sales cycle, moving prospects seamlessly from initial contact to conversion.
Buyer-Centric Focus: AI Maverick acts on buyer intent in real-time, ensuring leads are engaged at the perfect moment. "You need to enter the conversation already taking place in the customer's mind." - Robert Collier, early 20th century.
Tune in Now:
In the podcast, you'll hear insights on how AI Maverick is reshaping the sales landscape, from rapid MVP deployment to ensuring compliance at scale. Whether you're an investor, business leader, or tech enthusiast, this is a must-listen episode:
🎧 YouTube: https://youtu.be/DOQZxRYhmu0?si=KGBbSik46bBOzfCf
🎧 Spotify:https://open.spotify.com/episode/1OOHkCIiW7lnD0JckLJNqW?si=SYS5uebzQkGdU3-YxwwoWQ
Stay Connected
Stay updated on AI Maverick's journey as we gear up to launch AI Maverick 2.0, the next-generation platform that's set to redefine sales automation. Turn on press release notifications to catch every breakthrough.
For more information, please contact:
Wayne Cockburn, CEO
Phone: (905) 505-0770
[email protected]
About BizUnlearned Podcast:
BizUnlearned is the ultimate podcast for project managers, business leaders, and entrepreneurs looking to elevate their skills and foster meaningful connections. Hosted by industry experts William (Cowboy) H. Volpé III, a renowned project management authority, and Mark Layder, a visionary in business coaching and development, each episode dives deep into the latest trends, tools, and strategies driving successful projects and business growth. Join us for engaging discussions, real-world insights, and practical takeaways to thrive in today's dynamic business landscape.
https://projectvictories.com/bizunlearned-hosts/
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate", "believe", "continue", "could", "estimate", "expect", "intend", "may", "ongoing", "plan", "potential", "predict", "project", "should", "will", "would", or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on OTCmarkets.com.
SOURCE: Bionoid Pharma, Inc.
Ch.P.Lewis--AT